Study shows enhanced immunogenicity of heterologous boosting

Researchers from Singapore conducted a study to assess the spike protein-specific humoral and cellular immunity in Ad26.COV2.S vaccinated individuals either primed with Ad26.COV2.S only, or boosted with a homologous or heterologous second dose.

Related Keywords

Singapore , Astrazeneca Chadox , Sreetama Dutt , Pfizer , Johnson , Sreetama Duttm Sc Oct , Receptor Binding Domain , Coronavirus Disease Covid 19 , Vaccine , Antibodies , Ntibody , Fell , Coronavirus , Efficacy , Homologous , Immunity , Immunization , Protein , Eceptor , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Spike Protein , Yndrome ,